Wordt geladen...

The Promise of Neuroprotective Agents in Parkinson’s Disease

Parkinson’s disease (PD) is characterized by loss of dopamine neurons in the substantia nigra of the brain. Since there are limited treatment options for PD, neuroprotective agents are currently being tested as a means to slow disease progression. Agents targeting oxidative stress, mitochondrial dys...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Seidl, Stacey E., Potashkin, Judith A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Research Foundation 2011
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3221408/
https://ncbi.nlm.nih.gov/pubmed/22125548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2011.00068
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!